Product Information

RYMED TABLET is a brand product labeled by Edwards Pharmaceuticals, Inc., priced at $0.2240 per EA under NDC 00485008001. Its NADAC has been published 306 times since Jan 22, 2014.

OTC

Strength

2; 10 mg/1; mg/1

NDC

00485008001

Classification

Brand

Dosage Form

TABLET, COATED

Route

ORAL

Last Updated

1/1/2026

Approval Type

OTC MONOGRAPH DRUG

FDA Application

M012

On Market Since

11/15/2011

Pharmacological Classes

Adrenergic alpha1-Agonists
alpha-1 Adrenergic Agonist

Price Statistics

The NADAC for RYMED TABLET has been published 306 times since Jan 22, 2014, and over the history we have for it it has risen 54.0%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2240 per EA
All-time high$0.2240 (Jun 24, 2026)
All-time low$0.1454 (Jan 22, 2014)
52-week high$0.2240
52-week low$0.2098
Median price$0.1534
Average price$0.1732
Largest weekly change+31.3% (Apr 17, 2024)
Weeks tracked306
Tracking sinceJan 22, 2014

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+4.0%

1Y

+4.0%

3Y

+46.5%

5Y

+46.5%

All

+54.0%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the DEXCHLORPHENIRAMINE MALEATE and PHENYLEPHRINE HYDROCHLORIDE market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of RYMED TABLET?

The current National Average Drug Acquisition Cost (NADAC) for RYMED TABLET, manufactured by Edwards Pharmaceuticals, Inc., is $0.2240 per EA (NDC 00485008001), effective Jun 24, 2026.

How has the price of RYMED TABLET changed over time?

Over the history we have for it, the NADAC for RYMED TABLET has risen 54.0%. It has been tracked across 306 weekly CMS publications since Jan 22, 2014.

What are the highest and lowest recorded NADAC prices for RYMED TABLET?

Since Jan 22, 2014, the NADAC for RYMED TABLET has ranged from a low of $0.1454 (Jan 22, 2014) to a high of $0.2240 (Jun 24, 2026), with a median of $0.1534 per EA.

Are there cheaper alternatives to RYMED TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of RYMED TABLET, so no direct lower-cost alternative is listed.

Who manufactures RYMED TABLET?

RYMED TABLET (NDC 00485008001) is labeled by Edwards Pharmaceuticals, Inc., and CMS classifies it as a brand product.